Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
JHEP Reports : Innovation in Hepatology|June 17, 2024
Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinomaLinsey E Jackson, Jennifer L Tomlinson, Roberto Alva-Ruiz, et al.Journal of Hepatology|September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinomaCaitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.Hepatology (Baltimore, Md.)|March 20, 2025
Deep learning analysis of magnetic resonance imaging accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitisYashbir Singh, John E Eaton, Sudhakar K Venkatesh, et al.Cancers|May 14, 2022
Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and CholangiocarcinomaKatsuyuki Miyabe, Vinay Chandrasekhara, Nicha Wongjarupong, et al.Hepatology (Baltimore, Md.)|September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic targetDong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.Journal of Hepatology|May 5, 2025
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomasIrene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, et al.Journal of Hepatology|March 1, 2024
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in miceYan Yang, Jiale Wang, Jianhua Wan, et al.Signal Transduction and Targeted Therapy|August 17, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblastsJosep Amengual, Ester Gonzalez-Sanchez, Mariana Yáñez-Bartolome, et al.Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.Pageof 8